Maider Medical Industry Equipment Co (688310) Fair Value & Analysis
Healthcare · CN · Market cap 2.9B CNY
Fair value as of: Jul 12, 2026
From 26 valuation models · updated 29 days ago
Fair value updated Jul 12, 2026, revised from ¥8.58 to ¥6.75 (−21.3%) since Jun 24, 2026. Share price −3.6% over the past month.
A strong business, but screening 55% overvalued on our models.
What matters now
- A high-quality business (quality 79/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
- The price sits above even our optimistic bull case (¥8.44). The favourable scenario is already priced in.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.
How to read this chart
60‑month range ¥9.35 – ¥37.31 · fair‑value band ¥5.17 – ¥8.44 · the ¥15.10 price screens above the ¥6.75 fair value. Dashed = 300-day average. As of Jul 12, 2026.
Analysis
Maider Medical Industry Equipment Co (688310) currently trades at ¥15.10, while our model-based Fair Value estimate is ¥6.75, implying the stock looks roughly 55.3% overvalued today. The Quality Score stands at 79/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Maider Medical Industry Equipment Co generated revenue of 447M CNY at a net margin of 12.7%. Revenue declined 0.8% year over year. It earns a return on equity of 4.1%. The balance sheet holds a net cash position of 88.0M CNY. Fundamentals as of Jul 12, 2026
Our scenario range runs from ¥5.17 (bear case) to ¥8.44 (bull case); at ¥15.10, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 33% below its 52-week high and 12% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -43% fair-value upside, at -55%, 688310 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (¥13.10) versus Dividend Discount (¥0.1200). Highest evidence: Growth DCF (80).
Notify me when 688310 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 80 · Market factors (momentum, volatility) 38
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Maider Medical Industry Equipment Co. Ltd. engages in the research, development, production, sale, and service of intelligent equipment for medical consumables in China and internationally.
Full company description
Maider Medical Industry Equipment Co. Ltd. engages in the research, development, production, sale, and service of intelligent equipment for medical consumables in China and internationally. It offers blood purification solutions, including automatic assembly machine for hemodialyzer, AV fistula needle, peritoneal dialysis, powder barrel, hollow fiber membrane spinning, hemoperfusion cartridge, flushing syringe, and dialysis bloodline catheters, infusion sets, and central venous catheter; and transfusion solutions, such as automatic assembly machine for disposable infusion set. The company also provides biological reagents comprising a PCR automatic packaging product line; tube extrusion and cutting solutions, such as an automatic production machine for medical catheter; blood collection solutions consisting of automatic assembly machine for blood lancet, safety blood collection needle; and injection solutions, including an automatic assembly machine for pre-filled and safety syringe. In addition, it offers blood glucose solutions, such as automatic assembly machine for insulin pen, pen needle, and syringe; intervention solutions comprising automatic assembly machine for biopsy needle. Further, the company provides anesthesia solutions comprising automatic assembly for an extension set for the pump and spinal anesthesia needle; automatic assembly for the urinary catheter; and other combined products. Maider Medical Industry Equipment Co. Ltd. was founded in 2003 and is headquartered in Taizhou, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Maider Medical Industry Equipment Co reported revenue of ¥447M in FY2025 versus ¥316M in FY2021, a compound +9.1%/yr. Reported net income was ¥65.3M in FY2025, compounding +0.3%/yr from FY2021.
of which total revenue +14.1 pp · buybacks/dilution −6.2 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
688310 screens 55% overvalued. Compare with Intuitive Surgical, Inc →
Peer Group
Medical Instruments & Supplies · 203 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.33 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €172.45 | €68.55 | -60% |
| Medline Inc MDLN | $41.11 | $30.15 | -27% |
| Becton, Dickinson and Company BDX | $150.65 | $103.53 | -31% |
| Alcon Inc ALC | $70.26 | $39.78 | -43% |
| ResMed Inc RMD | $203.87 | $187.89 | -8% |
| West Pharmaceutical Services, Inc WST | $353.71 | $143.97 | -59% |
| Straumann Holding STMN | CHF 106.00 | CHF 47.31 | -55% |
| Sartorius Stedim Biotech S.A DIM | €188.50 | €51.16 | -73% |
| Coloplast A/S COLOB | kr 414.00 | kr 382.22 | -8% |
Compare Maider Medical Industry Equipment Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Maider Medical Industry Equipment Co (688310) overvalued or undervalued?
What is the fair value of 688310?
What is the quality score of 688310?
What is the revenue of Maider Medical Industry Equipment Co (688310)?
What is the net profit margin of 688310?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Maider Medical Industry Equipment Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.